GLAXO

GlaxoSmithKline Pharmaceuticals Share Price

₹2,411.80 +42.15 (1.78%)

23 Nov, 2024 00:09

SIP TrendupStart SIP in GLAXO

Start SIP

Performance

  • Low
  • ₹2,350
  • High
  • ₹2,440
  • 52 Week Low
  • ₹1,617
  • 52 Week High
  • ₹3,088
  • Open Price₹2,389
  • Previous Close₹2,370
  • Volume288,891

Investment Returns

  • Over 1 Month -8.77%
  • Over 3 Month -21.22%
  • Over 6 Month + 2.88%
  • Over 1 Year + 45.28%
SIP Lightning

Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!

Invest Now

GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 60.5
  • PEG Ratio
  • 14.4
  • Market Cap Cr
  • 40,857
  • P/B Ratio
  • 23
  • Average True Range
  • 86.51
  • EPS
  • 47.33
  • Dividend Yield
  • 1.8
  • MACD Signal
  • -57.95
  • RSI
  • 35.07
  • MFI
  • 40.78

GlaxoSmithKline Pharmaceuticals Financials

GlaxoSmithKline Pharmaceuticals Technicals

EMA & SMA

Current Price
₹2,411.80
+ 42.15 (1.78%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹2,535.60
  • 50 Day
  • ₹2,623.09
  • 100 Day
  • ₹2,612.70
  • 200 Day
  • ₹2,446.75

Resistance and Support

2400.57 Pivot Speed
  • R3 2,541.03
  • R2 2,490.47
  • R1 2,451.13
  • S1 2,361.23
  • S2 2,310.67
  • S3 2,271.33

What's your outlook on GlaxoSmithKline Pharmaceuticals?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

GlaxoSmithKline Pharmaceuticals Ltd., based in Mumbai, manufactures and distributes prescription medicines across therapeutic areas like dermatology, diabetes, and cardiovascular diseases. It also offers vaccines for hepatitis, influenza, chickenpox, and other infectious diseases in India and global markets.

Glaxosmithkline Pharms. has an operating revenue of Rs. 3,560.48 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 24% is great, ROE of 33% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-29 Quarterly Results & Interim Dividend
2024-08-02 Quarterly Results
2024-05-17 Audited Results & Final Dividend
2024-02-12 Quarterly Results
2023-11-09 Quarterly Results
Date Purpose Remarks
2024-11-07 INTERIM Rs.12.00 per share(120%)Interim Dividend
2024-05-31 FINAL Rs.32.00 per share(320%)Final Dividend
2023-06-30 FINAL Rs.32.00 per share(320%)Final Dividend
2022-07-08 FINAL Rs.30.00 per share(300%)Dividend
2022-07-08 SPECIAL Rs.60.00 per share(600%)Special Dividend

GlaxoSmithKline Pharmaceuticals F&O

GlaxoSmithKline Pharmaceuticals Shareholding Pattern

75%
4.98%
2.27%
4.36%
0.01%
10.97%
2.41%

About GlaxoSmithKline Pharmaceuticals

  • NSE Symbol
  • GLAXO
  • BSE Symbol
  • 500660
  • Managing Director
  • Mr. B Akshikar
  • ISIN
  • INE159A01016

Similar Stocks to GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals FAQs

GlaxoSmithKline Pharmaceuticals share price is ₹2,411 As on 22 November, 2024 | 23:55

The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹40857.3 Cr As on 22 November, 2024 | 23:55

The P/E ratio of GlaxoSmithKline Pharmaceuticals is 60.5 As on 22 November, 2024 | 23:55

The PB ratio of GlaxoSmithKline Pharmaceuticals is 23 As on 22 November, 2024 | 23:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23